2021
DOI: 10.1016/j.jcrc.2021.04.008
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 influences lung microbiota dynamics and favors the emergence of rare infectious diseases: A case report of Hafnia Alvei pneumonia.

Abstract: The coronavirus disease 2019 causes a wide degree of organ dysfunction and is associated with bacterial secondary infection. We reported lung microbiota dynamics in a critically ill patient with coronavirus disease 2019, who developed severe Hafnia alvei ventilator-associated pneumonia and required extracorporeal membrane oxygenation support.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 11 publications
(15 citation statements)
references
References 10 publications
(6 reference statements)
0
15
0
Order By: Relevance
“…It is normally isolated from the gastrointestinal tract of animals and humans and from food (Osuka et al, 2011). There are a number of reports on diseases associated with H. alvei and H. paralvei involved in a variety of animal and human infections (Real et al, 1997;Casagrande Proietti et al, 2004;Casanova-Román et al, 2004;Janda and Abbott, 2006;Osuka et al, 2011;Padilla et al, 2013;Orozova et al, 2014;Jayol et al, 2017;Litrenta and Oetgen, 2017;Rodríguez-Alarcón et al, 2019;Yin et al, 2019;Zhang et al, 2019;Cutuli et al, 2021). The main symptoms of H. alvei diseases included hepatosplenomegaly, multifocal nectrotizing hepatitis, and splenitis (Real et al, 1997;Casagrande Proietti et al, 2004;Orozova et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…It is normally isolated from the gastrointestinal tract of animals and humans and from food (Osuka et al, 2011). There are a number of reports on diseases associated with H. alvei and H. paralvei involved in a variety of animal and human infections (Real et al, 1997;Casagrande Proietti et al, 2004;Casanova-Román et al, 2004;Janda and Abbott, 2006;Osuka et al, 2011;Padilla et al, 2013;Orozova et al, 2014;Jayol et al, 2017;Litrenta and Oetgen, 2017;Rodríguez-Alarcón et al, 2019;Yin et al, 2019;Zhang et al, 2019;Cutuli et al, 2021). The main symptoms of H. alvei diseases included hepatosplenomegaly, multifocal nectrotizing hepatitis, and splenitis (Real et al, 1997;Casagrande Proietti et al, 2004;Orozova et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…No duplicates were found. We included in our analysis 447 cases—262 S. paucimobilis infections and 185 H. alvei infections ( Figure 3 ) [ 34 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 ].…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, the clinical case reported in Italy of H. alvei pneumonia under a COVID-19 patient described a severe disease progression, also with ECMO respiratory need, similar to our case. The authors conclude that COVID-19 influences the lung microbiota dynamics and favors the emergence of rare infectious diseases [15].…”
Section: Discussionmentioning
confidence: 96%
“…However, this bacterium can be responsible for serious infections in neonates [13] and adults, especially in hospitalized patients with underlying chronic diseases, subjected to invasive procedures or even under antibiotic treatment [14]. Moreover, despite the limited studies worldwide, H. alvei was previously related to pneumonia clinical condition [10,12,[15][16][17][18]. Herein we report a case of a critically ill patient with SARS-CoV-2 and Hafnia alvei respiratory co-infection.…”
Section: Introductionmentioning
confidence: 99%